Abstract
In our search for the mechanisms by which the drug 1-O-alkyl-2-O-methylglycero-3-phosphocholine (AMG-PC) inhibits tumor growth and metastasis, we have detected a metabolite, 1-O-alkyl-2-O-methylglycerol (AMG), in membranes of MO4 mouse fibrosarcoma cells grown in the presence of the drug. Synthetic AMG inhibited the activation of highly purified human protein kinase C by diacylglycerol in the presence of phosphatidylserine. Furthermore, AMG also inhibited the receptor-specific binding of3H-phorbol-12,13-dibutyrate to human HL-60 promyeloid leukemia cells in a dose-dependent fashion. AMG-PC was not effective or much less so in these assays. We suggest that interaction of the metabolite AMG with protein kinase C may inhibit stimulus-response coupling in tumor cells and may thus potentially contribute to the mechanism by which AMG-PC exerts its anticancer activities.
Similar content being viewed by others
Abbreviations
- AMG-PC:
-
1-O-alkyl-2-O-methylglycero-3-phosphocholine
- AMG:
-
1-O-alkyl-2-O-methylglycerol
- PKC:
-
protein kinase C
- diC8 :
-
1,2-dioctanoyl-sn-glycerol
- PS:
-
phosphatidylserine
- PMSF:
-
phenylmethylsulfonyl fluoride
- ATP:
-
adenosine 5′-triphosphate
- PDBu:
-
3H-phorbol-12,13-dibutyrate
- EGTA:
-
ethylene-glycol-bis(beta-aminoethylether)-N,N,N′,N′-tetraacetic acid
- TLC:
-
thin layer chromatography
References
Berdel, W.E., Andreesen, R., and Munder, P.G. (1985) inPhospholipids and Cellular Regulation (Kuo, J.F., ed.) Vol. II, pp. 41–73, CRC Press, Boca Raton, FL.
Van Blitterswijk, W.J., Hilkmann, H., and Storme, G.A. (1987)Lipids 22, 820–823.
Hoffman, D.R., Hoffman, L.H., and Snyder, F. (1986)Cancer Res. 46, 5803–5809.
Kikkawa, U., and Nishizuka, Y. (1986)Ann. Rev. Cell Biol. 2, 149–178.
Storme, G.A., Berdel, W.E., Van Blitterswijk, W.J., Bruyneel, E.A., de Bruyne, G.K., and Mareel, M.M. (1985)Cancer Res. 45, 351–357.
Meyvisch, C., and Mareel, M. (1982)Invasion Metastasis 2, 51–60.
Collins, S.J., Gallo, R.C., and Gallagher, R.E. (1977)Nature 270, 347–349.
Van Blitterswijk, W.J., Emmelot, P., Hilkmann, H.A.M., Hilgers, J., and Feltkamp, C.A. (1979)Int. J. Cancer. 23, 62–70.
Folch, J., Lees, M., and Sloane-Stanley, G.H. (1957)J. Biol. Chem. 226, 497–509.
Myher, J.J., and Kuksis, A. (1982)Can. J. Biochem. 60, 638–650.
Goodwin, B.J., and Weinberg, J.B., (1982)J. Clin. Invest. 70, 699–706.
Kikkawa, U., Takai, Y., Minakuchi, R., Inohara, S., and Nishizuka, Y. (1982)J. Biol. Chem. 257, 13341–13348.
Girard, P.R., Mazzei, G.J., Wood, J.G., and Kuo, J.F. (1985)Proc. Natl. Acad. Sci. USA 82, 3030–3034.
Laemmli, U.K. (1970)Nature 227, 680–685.
Kikkawa, U., Minakuchi, R., Takai, Y., and Nishizuka, Y. (1983)Methods Enzymol. 99, 288–298.
Fabiato, A., and Fabiato, F. (1979)J. Physiol. Paris 75, 463–505.
Boni, L.T., and Rando, R.R. (1985)J. Biol. Chem. 260, 10819–10825.
Helfman, D.M., Barnes, K.C., Kinkade Jr., J.M., Vogler, W.R., Shoji, M., and Kuo, J.F. (1983)Cancer Res. 43, 2955–2961.
Ebeling, J.G., Vandenbark, G.R., Kuhn, L.J., Ganong, B.R., Bell, R.M., and Niedel, J.E. (1985)Proc. Natl. Acad. Sci. USA 82, 815–819.
Nomura, H., Ase, K., Sekiguchi, K., Kikkawa, U., and Nishizuka, Y. (1986)Biochem. Biophys. Res. Commun. 140, 1143–1151.
Preiss, J., Loomis, C.R., Bishop, W.R., Stein, R., Niedel, J.E., and Bell, R.M. (1986)J. Biol. Chem. 261, 8597–8600.
Author information
Authors and Affiliations
About this article
Cite this article
van Blitterswijk, W.J., van der Bend, R.L., Kramer, Ï.M. et al. A metabolite of an antineoplastic ether phospholipid may inhibit transmembrane signalling via protein kinase C. Lipids 22, 842–846 (1987). https://doi.org/10.1007/BF02535541
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02535541